Oncoinvent ASA (KLDVK) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.58x

Oncoinvent ASA (KLDVK) has a Cash Flow Reinvestment Rate of 0.58x as of December 2025, reinvesting Nkr2.12 Million (capex Nkr2.12 Million ) from operating cash flow of Nkr3.64 Million. Check earnings quality score of Oncoinvent ASA to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.58x
(Capex + Investments) / Operating CF

Total Reinvested

Nkr2.12 Million
Capex + Investments

Operating Cash Flow

Nkr3.64 Million
NOK

Capital Expenditures

Nkr2.12 Million
NOK

Oncoinvent ASA Cash Flow Reinvestment Rate (2021–2022)

Historical reinvestment intensity for Oncoinvent ASA across 2 annual periods. Explore KLDVK cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Oncoinvent ASA (2021–2022)

Year-by-year capital reinvestment analysis for Oncoinvent ASA. For live market cap and broader valuation context, see KLDVK market cap overview.

Year Reinvestment Rate Total Reinvested (NOK) Operating CF Capex YoY Change
2022 32.49x Nkr12.12 Million Nkr373.06K Nkr12.12 Million ▼ -86.3%
2021 236.36x Nkr30.88 Million Nkr130.66K Nkr30.88 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow